SELECTION OF RATE VERSUS RHYTHM CONTROL FOR TREATMENT OF ATRIAL FIBRILLATION IN CLINICAL PRACTICE: RESULTS FROM THE ORBIT-AF REGISTRY
Benjamin A. Steinberg(University of Utah), Jonathan P. Piccini(Clinical Research Institute), Michael D. Ezekowitz(Lankenau Institute for Medical Research), Kenneth W. Mahaffey(Cardiovascular Institute of the South), Roger M. Mills(Janssen (Belgium)), James A. Reiffel(St. John's University), DaJuanicia N. Holmes(Duke University), Peter R. Kowey(Lankenau Institute for Medical Research), Eric D. Peterson(The University of Texas Southwestern Medical Center), Gerald V. Naccarelli(Clinical Research Institute)
Cited by 0
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k